MBAI
Check-capยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About MBAI
Check-Cap Ltd.
Innovators in non-invasive early screening for colorectal cancer use capsule free technology to unlock convenient and accurate monitoring of intestinal health
Healthcare Equipment and Supplies
04/05/2009
03/18/2015
NASDAQ Stock Exchange
85
12-31
Common stock
Abba Hushi Avenue
P.O. Box 1271
Isfiya
30090 Mount Carmel
Israel
--
Check-cap Ltd., was incorporated as a private company with limited liability under the laws of the State of Israel on April 5, 2009. The company is a clinical-stage medical diagnostic company that aims to redefine CRC screening by introducing C-Scan. C-Scan is the first and only patient-friendly unprepared test designed to detect polyps before they turn into cancer, enabling early intervention and cancer prevention.
Company Financials
EPS
MBAI has released its 2023 Q3 earnings. EPS was reported at -0.44, versus the expected -0.29, missing expectations. The chart below visualizes how MBAI has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
